# Child-Resistant Packaging Statements in Drug Product Labeling Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/child-resistant-packaging-statements-in-drug-product-labeling-guidance-for-industry/6c75fc9c-8e65-49a0-ad1d-eb6162ad92b8

> FDA guidance document: Child-Resistant Packaging Statements in Drug Product Labeling Guidance for Industry. Issue date: August 13, 2019. Get complete insights and analysis.

---

## Details

- Title: Child-Resistant Packaging Statements in Drug Product Labeling Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-08-13
- Last Changed: 2021-10-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-2163">FDA-2017-D-2163</a>

## Related Documents

- [Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-in-demonstrating-interchangeability-with-a-reference-product-guidance-for-industry/3c6c8653-5a0c-4cb1-b776-530e73843765)
- [Scientific Considerations in Demonstrating Biosimilarity to a Reference Product](https://www.globalkeysolutions.net/guidances/guidance-document/scientific-considerations-in-demonstrating-biosimilarity-to-a-reference-product/b98b0335-f4b7-4a14-88b1-7ea4d02c7e37)
- [Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/adaptive-design-clinical-trials-for-drugs-and-biologics-guidance-for-industry/97c6b6e1-4164-4fbe-8059-b0aa3fd39415)